Therapeutic compounds

Details Therapeutic compounds Therapeutic compounds

2007-07-06

2009-10-20

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S506000, C514S785000, C554S117000, C554S118000, C554S119000, C560S008000, C560S055000

Reexamination Certificate

active

07605178

ABSTRACT:
Disclosed herein are compounds of the formulatherapeutic methods, compositions, and medicaments related thereto are also disclosed.

REFERENCES:
patent: 3980700 (1976-09-01), Miyano
patent: 4073799 (1978-02-01), Kondo et al.
patent: 4094886 (1978-06-01), Kondo et al.
patent: 6531485 (2003-03-01), Cameron et al.
patent: 2003/0008895 (2003-01-01), Cameron et al.
patent: 2359955 (1975-06-01), None
patent: 2608116 (1976-11-01), None
patent: 2708871 (1977-10-01), None
patent: 180705 (1983-04-01), None
patent: 191196 (1987-01-01), None
patent: 51-110557 (1976-09-01), None
patent: 4-149153 (1992-05-01), None
patent: 2001-163779 (2001-06-01), None
patent: WO02/26704 (2002-04-01), None
patent: WO2005/026109 (2005-03-01), None
patent: WO 2006/112742 (2006-04-01), None
Stella, Valentino J, Expert Opinion of Therapeutic Patents, Prodrugs as therapeutics, 2004 14(3): 277-280.
Wolff et al. (Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994).
Testa, Bernard, Biochemical Pharmacology, Prodrug Research: futile or fertile? 68 (2004) 2097-2106.
Ettmayer, Peter, Medicinal Chemistry, Lessons Learned from Marketed and Investigational Prodrugs, 47(10) (2004) 2394-2404.
XP002461619 Database Caplus/Chemical Abstracts Service (HU191196).
XP002461620 Database Caplus/Chemical Abstracts Service (HU180705).
Kondo, et al., “Synthesis and Nucleophilic Ring-Opening Reactions of Activated Bicyclo-[3.1.0]Hexanes,” Tetrahedron Letters (1976) No. 49, pp. 4489-4492.
Kondo, et al., “A New Stereoselective Synthesis of Prostaglandins,” Chem, Biochem, Pharmacol. Act. Prostanoids (1979), Pergamon; Oxford, Engl; Meeting Date 1978:185-193.
P. De Clercq, et al., “1H-NMR Spectral Parameters of Some 1,4-Dihydroxy-2,3-Dialkylcyclopentanes . . . ,” Bull. Soc. Chim. Belg. vol. 85/No. 11/1976, pp. 872-882.
P. De Clerq, et al., “Prostaglandin Synthesis Involving Catalytic Hydrogenation . . . ,” Tetrahedron (1976) vol. 32, pp. 2747-2752.

Affiliated with

Also associated with

Rating

Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083845